Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib

OBJECTIVE: Pain reduction with baricitinib was assessed in patients with rheumatoid arthritis (RA) who either used opioids or did not use opioids during three randomized, double‐blind phase 3 trials. METHODS: Analysis populations were as follows: i) baricitinib 4 mg once daily versus placebo groups...

Descripción completa

Detalles Bibliográficos
Autores principales: Pope, Janet E., Lee, Yvonne C., Curtis, Jeffrey R., Mo, Daojun, Xie, Li, Dickson, Christina L., Schlichting, Douglas E., Cardoso, Anabela, Simon, Lee S., Taylor, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916571/
https://www.ncbi.nlm.nih.gov/pubmed/34913611
http://dx.doi.org/10.1002/acr2.11380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916571/
https://www.ncbi.nlm.nih.gov/pubmed/34913611
http://dx.doi.org/10.1002/acr2.11380

Ejemplares similares